
Craig Wozniak, head Americas region, clinical operations at GlaxoSmithKline, discusses TransCelerate and it's impact on the clinical trials industry and risk-based monitoring

Risk-Based Monitoring – Part Two In Depth Review

Snapshot Shows Targeted Site Monitoring Trend

Has FDA Guidance on Risk-based Monitoring Impacted SDV Coverage Yet?

News

Craig Wozniak, Head Americas Region, Clinical Operations at GlaxoSmithKline, discusses TransCelerate and it's impact on the clinical trials industry and risk-based monitoring